EVALUATION OF HEALTH CARE UTILIZATION, HOSPITALIZATION/EMERGENCY ROOM COSTS, AND OTHER MEDICATION USE AMONG CROHN'S DISEASE PATIENTS USING USTEKINUMAB IN THREE LARGE UNITED STATES COMMERCIAL CLAIMS DATABASES

被引：0
|
作者：
Obando, Camilo
Ding, Zhijie
Muser, Erik
Vaidya, Neel
Qiang, Wenqin
Sun, Xiaoxi
Wang, Huiqi
Mallampati, Rajesh
Xie, Lin
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1909
引用
收藏
页码：S882 / S882
页数：1
相关论文
共 11 条
  • [1] EVALUATION OF USTEKINUMAB TREATMENT PATTERNS AMONG CROHN'S DISEASE PATIENTS IN THREE LARGE US COMMERCIAL CLAIMS DATABASES
    Obando, Camilo
    Ding, Zhijie
    Muser, Erik
    Vaidya, Neel
    Qiang, Wenqin
    Sun, Xiaoxi
    Wang, Huiqi
    Mallampati, Rajesh
    Xie, Lin
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S882 - S882
  • [2] EVALUATION OF BIOLOGIC TREATMENT PATTERNS AMONG CROHN'S DISEASE PATIENTS USING THREE LARGE UNITED STATES CLAIMS DATABASES
    Muser, Erik
    Obando, Camilo
    Teeple, Amanda M.
    Bibeau, Wendy
    Sah, Janvi
    Mallampati, Rajesh
    Wang, Huiqi
    Xie, Lin
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S958 - S959
  • [3] TREATMENT PATTERNS IN BIOLOGIC-EXPERIENCED CROHN'S DISEASE PATIENTS USING THREE LARGE COMMERCIAL CLAIMS DATABASES IN THE UNITED STATES
    Teeple, Amanda M.
    Sah, Janvi
    Mallampati, Rajesh
    Adams, Christopher
    Waters, Dexter D.
    Muser, Erik
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S696 - S697
  • [4] Persistence, Dose Titration, and Health Care Resource Utilization Among Crohn’s Disease Patients Treated With Ustekinumab: A Real-World Analysis in the United States
    Camilo Obando
    Zhijie Ding
    Erik Muser
    Neel Vaidya
    Wenqin Qiang
    Xiaoxi Sun
    Huiqi Wang
    Rajesh Mallampati
    Lin Xie
    [J]. Advances in Therapy, 2020, 37 : 2127 - 2143
  • [5] Persistence, Dose Titration, and Health Care Resource Utilization Among Crohn's Disease Patients Treated With Ustekinumab: A Real-World Analysis in the United States
    Obando, Camilo
    Ding, Zhijie
    Muser, Erik
    Vaidya, Neel
    Qiang, Wenqin
    Sun, Xiaoxi
    Wang, Huiqi
    Mallampati, Rajesh
    Xie, Lin
    [J]. ADVANCES IN THERAPY, 2020, 37 (05) : 2127 - 2143
  • [6] Health Plan Paid Costs and Drivers of Health Care Costs for Patients With Crohn's Disease Insured At Six Different Commercial Health Plans in the United States
    Rubin, David T.
    Colletti, Richard B.
    Sharma, Bal K.
    Thompson, Amy
    Krueger, Andrew
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S635 - S635
  • [7] Treatment Patterns Among Crohn's Disease Patients Initiating Biologics: A Two-Year Pooled Analysis of Three United States Claims Databases
    Muser, Erik
    Teeple, Amanda
    Sah, Janvi
    Adams, Christopher
    Waters, Dexter
    Ding, Zhijie
    Gutierrez, Cynthia
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S337 - S338
  • [8] Burden of Herpes Zoster Among Patients With Ulcerative Colitis and Crohn's Disease in the United States: A Retrospective Cohort Study Using a Large Administrative Claims Database
    Singer, David
    Thompson-Leduc, Philippe
    Poston, Sara
    Gupta, Deepshekhar
    Cheng, Wendy Y.
    Ma, Siyu
    Pawlowski, John E.
    Duh, Mei Sheng
    Devine, Francesca
    Banatwala, Azeem
    Bernstein, Emma
    Farraye, Francis A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S419 - S420
  • [9] EVALUATION OF HEALTH CARE RESOURCE UTILIZATION AND COSTS AMONG BIO NAIVE CROHN'S DISEASE PATIENTS INITIATING BIOLOGICS WITH TWO YEARS OF FOLLOW-UP
    Cyhaniuk, A.
    Zhao, R.
    Ding, Z.
    Gupta, P.
    Kachroo, S.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S388 - S389
  • [10] EVALUATION OF HEALTH CARE RESOURCE UTILIZATION AND COSTS AMONG BIO-EXPERIENCED CROHN'S DISEASE PATIENTS TREATED WITH BIOLOGICS WITH TWO YEARS OF FOLLOW-UP
    Cyhaniuk, A.
    Zhao, R.
    Ding, Z.
    Gupta, P.
    Kachroo, S.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S429 - S429
12